BridgeMD
New treatment option for Postpartum Hemorrhage
Official title Temporary Aortic Compression With the Abdominal Tourniquet for Refractory Postpartum Hemorrhage
ClinicalTrials.gov ID: NCT07034924
What this study is testing
- What it's testing
- This multicenter study aims to evaluate effectiveness and safety of using the AAJT-S device as a temporary intervention for severe, atony-related PPH that is refractory to standard therapies
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- Age ≥18 years
- Clinical diagnosis of postpartum hemorrhage (PPH) refractory to uterotonics and intrauterine balloon tamponade
- Estimated blood loss greater than 1300 mL
- Oral informed consent provided prior to device application
You likely can't join if
- Patients with postpartum bleeding as a result of trauma, retained placenta or coagulopathy were excluded
The study team makes the final eligibility decision.
Where it's taking place
- Zaporizhzhia, Ukraine
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zaporizhzhia, Ukraine. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.